MS in Regenerative Medicine in UK 2025
Pioneer the therapies that will replace damaged tissues and organs — the UK leads globally in regenerative medicine regulation and clinical translation with direct links to MHRA and leading cell therapy companies.
Get Free Guidance — 0% CommissionKey Facts About Studying Regenerative Medicine in the UK
| Aspect | Details |
|---|---|
| Top Universities | University College London, King's College London, University of Manchester, Keele University |
| Program Duration | 1 year full-time |
| Language | English |
| Key Modules | Stem cell biology, tissue engineering, gene therapy, GMP manufacturing, regulatory pathway for ATMPs, clinical trial design |
| Tuition Fees | £22,000–£28,000/year for international students |
| Scholarships | BBSRC, MRC, Innovate UK fellowships, university bursaries, Cell and Gene Therapy Catapult grants |
| Career Roles | Cell Therapy Scientist, Regenerative Medicine Researcher, GMP Manufacturing Specialist, Regulatory Affairs Manager, ATMP Consultant |
| Post-Study Visa | Graduate Route 2 years |
| Industry Access | Cell and Gene Therapy Catapult (Stevenage), Oxford Biomedica, Autolus, Freeline Therapeutics all recruit UK MSc graduates |
| IELTS Requirement | 7.0 overall |
The UK's Cell and Gene Therapy Catapult in Stevenage is the world's largest dedicated cell and gene therapy manufacturing and development centre, and the MHRA's Advanced Therapy Medicinal Products (ATMP) regulatory framework is a global benchmark. UCL and King's College London's regenerative medicine programmes have direct ties to clinical trials running in NHS hospitals — giving MSc students access to translational research at the frontier of medicine. The CAR-T therapy market alone is projected to reach $20 billion by 2030, driven by manufacturing scale-up that demands trained GMP scientists.